Print

Purpose

The purpose of this study is to find out whether a urine test can detect colorectal cancer (CRC) and precancerous polyps in participants living in Ghana, Tanzania, and South Africa.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Criteria

Inclusion Criteria:

- Patient presents with one of the following:

- Patients with symptoms of CRC (such as rectal bleeding for a week) -OR-

- Patients who present for a screening colonoscopy -OR-

- Has received one of the following within 3 weeks of the planned urine
collection

- Patients with a pathologic diagnosis of CRC either by colonoscopy or
resection specimens -OR-

- Patients with colonoscopy demonstrating adenomatous polyps -OR-

- Patients with colonoscopy demonstrating no colon or premalignant or
malignant pathology

- Age ≥ 18

- Willingness to participate in the study

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Participants with Colorectal Cancer/CRC Participants will either have symptoms of colorectal cancer/CRC, presented for a screening colonoscopy, or one of the following: pathologic diagnosis of CRC, colonoscopy demonstrating adenomatous polyps, or colonoscopy demonstrating no colon or premalignant or malignant pathology
  • Diagnostic Test: 3-metabolite biosensor
    3-metabolite biosensor will identify participants with colorectal cancer (CRC) and precancerous polyps

Recruiting Locations

Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York 10065
Contact:
Peter Kingham, MD
212-639-5260

More Details

Status
Recruiting
Sponsor
Memorial Sloan Kettering Cancer Center

Study Contact

Peter Kingham, MD
212-639-5260
kinghamP@mskcc.org

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.